Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-18

Clinical Trial Update: Safety and Efficacy of Vilazodone in Major Depressive Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the safety and efficacy of vilazodone for major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vilazodone (vilazodone)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED